Placebo matching Vicadrostat clinical trials
3 indexed studies · 2 currently recruiting
- RecruitingPHASE3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
This clinical trial is testing whether a new medicine called vicadrostat can better protect the heart. It is given alongside an existing medicine, empagliflozin, to adults who have type 2 diabetes, high blood pressure, and heart disease. Researchers want to see if this combination lowers the risk of heart complications.
For: Diabetes Mellitus, Type 2 · Hypertension · Cardiovascular DiseasesUnited States · Argentina · Australia - Active not recruitingPHASE2
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
This study looks at a new medicine, vicadrostat, combined with empagliflozin, for adults with chronic kidney disease. Participants will take pills daily for 3 months, with regular checks on their kidney health and general well-being. It aims to see if starting medicines at different times impacts results.
For: Chronic Kidney DiseaseUnited States · Argentina · Australia - RecruitingPHASE1
A Study in Healthy People to Test How Vicadrostat Affects the Heart
This study is looking at how a new medicine, Vicadrostat, affects the heart in healthy adults. Researchers will compare Vicadrostat to a dummy medicine (placebo) to see if there are any differences. Moxifloxacin, another medicine, will also be used in some people.
For: HealthyGermany